Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry)

dc.contributor.authorKiris, Tuncay
dc.contributor.authorAvcı, Eyüp
dc.contributor.authorEkin, Tuba
dc.contributor.authorAkgün, Didar Elif
dc.contributor.authorTiryaki, Mücahit
dc.contributor.authorYidirim, Arafat
dc.contributor.authorHazır, Kutluhan
dc.contributor.authorMurat, Bektaş
dc.contributor.authorYeni, Mehtap
dc.contributor.authorAltındağ, Rojhad
dc.contributor.authorGül, Sefa
dc.contributor.authorArık, Baran
dc.contributor.authorGüzel, Tuncay
dc.contributor.authorMurat, Selda
dc.contributor.authorÖz, Ahmet
dc.contributor.authorKarabacak, Mustafa
dc.contributor.authorAktaş, Zihni
dc.contributor.authorYıldırım, Tarık
dc.contributor.authorKılıçaslan, Barış
dc.contributor.authorErgene, Asim Oktay
dc.date.accessioned2021-06-17T10:31:05Z
dc.date.available2021-06-17T10:31:05Z
dc.date.issued2021en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalıen_US
dc.descriptionWOS:000655937200001
dc.descriptionPMID: 34050883
dc.description.abstractObjective We aimed to investigate both the impact of COVID-19 pandemic on ST-segment elevation myocardial infarction (STEMI) admission, and demographic, angiographic, procedural characteristics, and in-hospital clinical outcomes of patients with COVID-19 positive STEMI in Turkey. Methods This was a multi-center and cross-sectional observational study. The study population included 1788 STEMI patients from 15 centers in Turkey. The patients were divided into two groups: COVID-19 era (March 11st–May 15st, 2020; n=733) or pre- COVID-19 era group (March 11st–May 15st, 2019; n=1055). Also, the patients in COVID-19 era were grouped as COVID-19 positive (n=65) or negative (n=668). Results There was a 30.5% drop in STEMI admission during COVID-19 era in comparison to pre-COVID-19 era. The patients admitted to the medical centers during COVID-19 era had a longer symptom-to-frst medical contact time [120 (75–240) vs. 100 (60–180) minutes, p<0.001]. COVID-19 positive STEMI patients had higher thrombus grade and lower left ventricular ejection fraction compared to COVID-19 negative patients. COVID-19 positive patients had higher mortality (28% vs. 6%, p<0.001) and cardiogenic shock (20% vs. 7%, p<0.001) rates compared with those without COVID-19. Matching based on propensity scores showed higher mortality and high thrombus grade in STEMI patients who were infected by SARS-COV-2 (each p<0.05). Conclusions We detected signifcantly lower STEMI hospitalization rates and signifcant delay in duration of symptom onset to frst medical contact in the context of Turkey during the COVID-19 outbreak. Moreover, high thrombus grade and mortality were more common in COVID-19 positive STEMI patients.en_US
dc.identifier.citationKiris, T., Avcı, E., Ekin, T., Akgün, D.E., Tiryaki, M., Yidirim, A. ve diğerleri. (2021). Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry). Journal of Thrombosis and Thrombolysis, Early access. 1-14.en_US
dc.identifier.doi10.1007/s11239-021-02487-3
dc.identifier.endpage14en_US
dc.identifier.issn0929-5305
dc.identifier.issn1573-742X
dc.identifier.pmid34050883
dc.identifier.scopus2-s2.0-85107012221
dc.identifier.scopusqualityQ1
dc.identifier.startpage1en_US
dc.identifier.urihttps://link.springer.com/content/pdf/10.1007/s11239-021-02487-3.pdf
dc.identifier.urihttps://hdl.handle.net/11468/7113
dc.identifier.volumeEarly Accessen_US
dc.identifier.wosWOS:000655937200001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorArık, Baran
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofJournal of Thrombosis and Thrombolysis
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV2en_US
dc.subjectST elevation myocardial infarctionen_US
dc.subjectPrimary percutaneous coronaryen_US
dc.subjectInterventionen_US
dc.subjectMortalityen_US
dc.titleImpact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry)en_US
dc.titleImpact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry)
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey.pdf
Boyut:
906.62 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: